Latest Insider Transactions at Steris PLC (STE)
This section provides a real-time view of insider transactions for Steris PLC (STE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of STERIS plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of STERIS plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 25
2021
|
Cynthia L Feldmann Director |
SELL
Open market or private sale
|
Direct |
4,000
-73.89%
|
$760,000
$190.84 P/Share
|
|
May 25
2021
|
Cynthia L Feldmann Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+42.49%
|
$268,000
$67.73 P/Share
|
|
May 21
2021
|
Jacqueline B Kosecoff Director |
SELL
Open market or private sale
|
Direct |
3,121
-100.0%
|
$599,232
$192.59 P/Share
|
|
May 21
2021
|
Jacqueline B Kosecoff Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,121
+50.0%
|
$96,751
$31.61 P/Share
|
|
Apr 23
2021
|
Julia Madsen Sr. VP and GM, Life Sciences |
SELL
Open market or private sale
|
Direct |
1,000
-17.73%
|
$215,000
$215.0 P/Share
|
|
Apr 23
2021
|
Julia Madsen Sr. VP and GM, Life Sciences |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+15.06%
|
$69,000
$69.72 P/Share
|
|
Apr 20
2021
|
Julia Madsen Sr. VP and GM, Life Sciences |
SELL
Open market or private sale
|
Direct |
1,000
-17.73%
|
$210,000
$210.0 P/Share
|
|
Apr 20
2021
|
Julia Madsen Sr. VP and GM, Life Sciences |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+15.06%
|
$69,000
$69.72 P/Share
|
|
Jan 08
2021
|
Julia Madsen Sr. VP and GM, Life Sciences |
SELL
Open market or private sale
|
Direct |
1,000
-17.73%
|
$202,000
$202.0 P/Share
|
|
Jan 08
2021
|
Julia Madsen Sr. VP and GM, Life Sciences |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+8.32%
|
$67,000
$67.94 P/Share
|
|
Dec 01
2020
|
David B Lewis Director |
SELL
Open market or private sale
|
Direct |
1,560
-18.92%
|
$301,080
$193.79 P/Share
|
|
Dec 01
2020
|
David B Lewis Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,560
+15.91%
|
$48,360
$31.61 P/Share
|
|
Nov 30
2020
|
Jacqueline B Kosecoff Director |
SELL
Bona fide gift
|
Indirect |
17,930
-22.69%
|
-
|
|
Nov 09
2020
|
Julia Madsen Sr. VP and GM, Life Sciences |
SELL
Open market or private sale
|
Direct |
1,900
-15.76%
|
$364,800
$192.46 P/Share
|
|
Nov 09
2020
|
Julia Madsen Sr. VP and GM, Life Sciences |
BUY
Exercise of conversion of derivative security
|
Direct |
1,900
+13.49%
|
$93,100
$49.43 P/Share
|
|
Nov 09
2020
|
Walter M Rosebrough Jr President & CEO |
SELL
Open market or private sale
|
Direct |
10,000
-5.64%
|
$1,940,000
$194.09 P/Share
|
|
Nov 06
2020
|
Walter M Rosebrough Jr President & CEO |
SELL
Open market or private sale
|
Direct |
10,000
-4.85%
|
$1,810,000
$181.44 P/Share
|
|
Nov 05
2020
|
Karen L Burton VP & CAO |
SELL
Open market or private sale
|
Direct |
4,602
-24.35%
|
$823,758
$179.43 P/Share
|
|
Nov 05
2020
|
Karen L Burton VP & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,852
+20.97%
|
-
|
|
Nov 05
2020
|
Cary L Majors SVP and President, Healthcare |
SELL
Open market or private sale
|
Direct |
2,000
-11.68%
|
$360,000
$180.0 P/Share
|
|
Nov 05
2020
|
Walter M Rosebrough Jr President & CEO |
SELL
Bona fide gift
|
Direct |
4,897
-6.42%
|
-
|
|
Oct 09
2020
|
Michael J Tokich Sr. Vice Pres., CFO |
SELL
Open market or private sale
|
Direct |
27,920
-14.49%
|
$5,248,960
$188.14 P/Share
|
|
Oct 09
2020
|
Michael J Tokich Sr. Vice Pres., CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
27,920
+27.54%
|
$1,479,760
$53.52 P/Share
|
|
Oct 08
2020
|
Michael J Tokich Sr. Vice Pres., CFO |
SELL
Open market or private sale
|
Direct |
80
-0.18%
|
$14,960
$187.0 P/Share
|
|
Oct 08
2020
|
Michael J Tokich Sr. Vice Pres., CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
80
+0.18%
|
$4,240
$53.52 P/Share
|
|
Oct 06
2020
|
Daniel A Carestio President and CEO |
SELL
Open market or private sale
|
Direct |
13,500
-7.91%
|
$2,457,000
$182.59 P/Share
|
|
Oct 06
2020
|
Daniel A Carestio President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
13,500
+25.32%
|
$1,039,500
$77.07 P/Share
|
|
Oct 01
2020
|
Julia Madsen Sr. VP and GM, Life Sciences |
BUY
Grant, award, or other acquisition
|
Direct |
1,396
+23.12%
|
-
|
|
Oct 01
2020
|
John Adam Zangerle Sr. VP, Gen Counsel, and Sec. |
SELL
Open market or private sale
|
Direct |
12,252
-29.78%
|
$2,180,856
$178.0 P/Share
|
|
Oct 01
2020
|
John Adam Zangerle Sr. VP, Gen Counsel, and Sec. |
BUY
Exercise of conversion of derivative security
|
Direct |
12,252
+22.95%
|
$649,356
$53.52 P/Share
|